NICE Agrees to Allow Ofev Therapy for Non-IPF Patients in UK

NICE Agrees to Allow Ofev Therapy for Non-IPF Patients in UK

310003

NICE Agrees to Allow Ofev Therapy for Non-IPF Patients in UK

Clinicians in the U.K. will now be able to prescribe the antifibrotic medicine Ofev (nintedanib) to people with non-idiopathic pulmonary fibrosis (PF) under a new decision by the National Institute for Health and Care Excellence (NICE). That decision came following a five-year campaign led by the U.K. charity Action for Pulmonary Fibrosis — and supported by patients, families, and pulmonary disease specialists. “This is a game changer for patients with progressive fibrosis,” Nazia Chaudhuri, PhD,…

You must be logged in to read/download the full post.